Effect of Third‐Generation Beta Blockers on Weight Loss in a Population of Overweight‐Obese Subjects in a Controlled Dietary Regimen
MA Gammone, K Efthymakis… - Journal of Nutrition and …, 2021 - Wiley Online Library
Background. Overweight and obesity often develop in individuals with genetic susceptibility
and concomitant risk factors; however, medications can represent precipitating factors in …
and concomitant risk factors; however, medications can represent precipitating factors in …
Adverse effects of β-blocker therapy on weight loss in response to a controlled dietary regimen
M Azar, M Nikpay, ME Harper, R McPherson… - Canadian Journal of …, 2016 - Elsevier
Background The effects of β-blockers on metabolic parameters including weight loss are
poorly understood. Methods From a database of 3582 patients who completed The Ottawa …
poorly understood. Methods From a database of 3582 patients who completed The Ottawa …
Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?
P Lee, AP Kengne, JR Greenfield, RO Day… - International Journal of …, 2011 - nature.com
Background: Sympathetic activation is an important metabolic adaptation limiting weight
gain. Propensity of weight gain associated with β-blocker therapy in the obese modern …
gain. Propensity of weight gain associated with β-blocker therapy in the obese modern …
Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain: A Systematic Analysis
One of the arguments put forward against the primary use of β-blockers has been concern
about adverse metabolic effects, such as unfavorable effects on lipids or insulin sensitivity …
about adverse metabolic effects, such as unfavorable effects on lipids or insulin sensitivity …
Use of beta‐blockers in obesity hypertension: potential role of weight gain
Beta‐blockers are the most frequently used drugs for the treatment of hypertension. Apart
from concerns regarding potential adverse metabolic effects on lipids or insulin sensitivity …
from concerns regarding potential adverse metabolic effects on lipids or insulin sensitivity …
Body weight changes with β-blocker use: results from GEMINI
FH Messerli, DSH Bell, V Fonseca, RE Katholi… - The American journal of …, 2007 - Elsevier
PURPOSE: Patients with type 2 diabetes are commonly overweight, which can contribute to
poor cardiovascular outcomes. β-blockers may promote weight gain, or hamper weight loss …
poor cardiovascular outcomes. β-blockers may promote weight gain, or hamper weight loss …
[PDF][PDF] Effect of beta-blockers on insulin resistance in patients with hypertension and metabolic syndrome after 6 months of treatment
Y Sirenko, O Rekovets, O Torbas… - J. Endocrinol …, 2017 - pdfs.semanticscholar.org
Catalase polymorphism May Influence the Pathogenesis of Diabetes Mellitus Page 1 *Corresponding
author email: annwyne.houldsworth@gmail.ac.uk. Symbiosis Group Symbiosis www.symbiosisonline.org …
author email: annwyne.houldsworth@gmail.ac.uk. Symbiosis Group Symbiosis www.symbiosisonline.org …
Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects.
M MacLachlan, AA Connacher… - International journal of …, 1991 - europepmc.org
Psychological aspects of dieting, including hunger and satiety sensations were explored in
obese subjects during a placebo-controlled trial of the weight reducing potential of BRL …
obese subjects during a placebo-controlled trial of the weight reducing potential of BRL …
Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy
M Cataldi, O di Geronimo, R Trio, A Scotti… - BMC Pharmacology and …, 2016 - Springer
Background Although the pathophysiological mechanisms of arterial hypertension are
different in obese and lean patients, hypertension guidelines do not include specific …
different in obese and lean patients, hypertension guidelines do not include specific …
Obesity and beta‐blockers: influence of body fat on their kinetics and cardiovascular effects
F Galletti, ML Fasano, LA Ferrara… - The Journal of …, 1989 - Wiley Online Library
Beta‐blockers are among the most widely used antihypertensive drugs. They differ from
each other in regard to several factors such as: β‐agonist activity, β1‐selectivity and …
each other in regard to several factors such as: β‐agonist activity, β1‐selectivity and …
相关搜索
- obese subjects weight loss
- beta blockers weight loss
- adverse effects weight loss
- beta blockers cardiovascular effects
- beta blockers obesity hypertension
- obese subjects psychological aspects
- beta blockers body fat
- adverse effects β blocker
- receptor blockers weight gain
- β blocker body weight
- psychological aspects weight loss
- beta blockers weight gain
- β blocker weight loss